Cite
HARVARD Citation
Platt, H. et al. (n.d.). P08 A Phase 1, randomized, double-blind study to evaluate the safety, tolerability, and immunogenicity of a 21-valent pneumococcal conjugate vaccine (PCV) (V116) in adults. JAC-antimicrobial resistance. p. . [Online].